HEADER TRANSFERASE 10-AUG-06 2I0E TITLE STRUCTURE OF CATALYTIC DOMAIN OF HUMAN PROTEIN KINASE C TITLE 2 BETA II COMPLEXED WITH A BISINDOLYLMALEIMIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN KINASE C-BETA II; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 321-673; COMPND 5 EC: 2.7.11.13; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PACSG2 KEYWDS PROTEIN KINASE C BETA II, PROTEIN KINASE C, KEYWDS 2 SERINE/THREONINE PROTEIN KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR N.B.GRODSKY,R.L.LOVE REVDAT 3 24-FEB-09 2I0E 1 VERSN REVDAT 2 05-DEC-06 2I0E 1 JRNL REVDAT 1 14-NOV-06 2I0E 0 JRNL AUTH N.GRODSKY,Y.LI,D.BOUZIDA,R.LOVE,J.JENSEN,B.NODES, JRNL AUTH 2 J.NONOMIYA,S.GRANT JRNL TITL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN JRNL TITL 2 KINASE C BETA II COMPLEXED WITH A JRNL TITL 3 BISINDOLYLMALEIMIDE INHIBITOR JRNL REF BIOCHEMISTRY V. 45 13970 2006 JRNL REFN ISSN 0006-2960 JRNL PMID 17115692 JRNL DOI 10.1021/BI061128H REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 31651 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.237 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.290 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.100 REMARK 3 FREE R VALUE TEST SET COUNT : 670 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2255 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.72 REMARK 3 BIN R VALUE (WORKING SET) : 0.3380 REMARK 3 BIN FREE R VALUE SET COUNT : 50 REMARK 3 BIN FREE R VALUE : 0.3640 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5112 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 115 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 65.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 54.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.40000 REMARK 3 B22 (A**2) : -0.90000 REMARK 3 B33 (A**2) : 0.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.438 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.310 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.259 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 12.644 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.900 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5318 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7187 ; 1.329 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 627 ; 6.280 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 251 ;35.243 ;24.502 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 928 ;19.756 ;15.032 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;17.487 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 736 ; 0.106 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4043 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2383 ; 0.214 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3599 ; 0.314 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 182 ; 0.139 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 35 ; 0.275 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 3 ; 0.146 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3218 ; 0.556 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5058 ; 0.996 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2424 ; 1.055 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2129 ; 1.747 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 2I0E COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-AUG-06. REMARK 100 THE RCSB ID CODE IS RCSB038979. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-SEP-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32375 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.04900 REMARK 200 R SYM (I) : 0.04900 REMARK 200 FOR THE DATA SET : 28.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.48400 REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: AKT-1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.83 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M ADA, 2.5 M SODIUM ACETATE, PH REMARK 280 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 46.54900 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 65.70850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 46.54900 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 65.70850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 30840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 93.09800 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 131.41700 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 THR A 321 REMARK 465 THR A 322 REMARK 465 ASN A 323 REMARK 465 THR A 324 REMARK 465 VAL A 325 REMARK 465 SER A 326 REMARK 465 LYS A 327 REMARK 465 PHE A 328 REMARK 465 ASP A 329 REMARK 465 ASN A 330 REMARK 465 ASN A 331 REMARK 465 GLY A 332 REMARK 465 ASN A 333 REMARK 465 ARG A 334 REMARK 465 ASP A 335 REMARK 465 ARG A 336 REMARK 465 MET A 337 REMARK 465 LYS A 338 REMARK 465 ASN A 625 REMARK 465 ALA A 626 REMARK 465 GLU A 670 REMARK 465 VAL A 671 REMARK 465 LYS A 672 REMARK 465 SER A 673 REMARK 465 THR B 321 REMARK 465 THR B 322 REMARK 465 ASN B 323 REMARK 465 THR B 324 REMARK 465 VAL B 325 REMARK 465 SER B 326 REMARK 465 LYS B 327 REMARK 465 PHE B 328 REMARK 465 ASP B 329 REMARK 465 ASN B 330 REMARK 465 ASN B 331 REMARK 465 GLY B 332 REMARK 465 ASN B 333 REMARK 465 ARG B 334 REMARK 465 ASP B 335 REMARK 465 ARG B 336 REMARK 465 MET B 337 REMARK 465 LYS B 338 REMARK 465 CYS B 622 REMARK 465 GLY B 623 REMARK 465 ARG B 624 REMARK 465 ASN B 625 REMARK 465 ALA B 626 REMARK 465 GLU B 627 REMARK 465 ASN B 628 REMARK 465 PHE B 629 REMARK 465 ASP B 630 REMARK 465 ARG B 631 REMARK 465 PHE B 632 REMARK 465 PHE B 633 REMARK 465 THR B 634 REMARK 465 ARG B 635 REMARK 465 HIS B 636 REMARK 465 PRO B 637 REMARK 465 PRO B 638 REMARK 465 VAL B 639 REMARK 465 LEU B 640 REMARK 465 TPO B 641 REMARK 465 PRO B 642 REMARK 465 PRO B 643 REMARK 465 ASP B 644 REMARK 465 GLN B 645 REMARK 465 GLU B 646 REMARK 465 VAL B 647 REMARK 465 ILE B 648 REMARK 465 ARG B 649 REMARK 465 ASN B 650 REMARK 465 GLU B 670 REMARK 465 VAL B 671 REMARK 465 LYS B 672 REMARK 465 SER B 673 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 362 93.22 3.81 REMARK 500 ASP A 365 41.49 -94.19 REMARK 500 ASP A 382 60.13 37.86 REMARK 500 ASP A 466 33.64 -142.52 REMARK 500 ASP A 484 88.95 68.91 REMARK 500 PRO A 505 -54.88 -28.30 REMARK 500 TYR A 515 26.16 43.14 REMARK 500 MET A 576 30.39 -98.43 REMARK 500 PRO A 643 97.04 -40.00 REMARK 500 ASP A 652 93.20 -64.42 REMARK 500 THR B 340 22.23 -73.22 REMARK 500 LYS B 362 84.46 -9.02 REMARK 500 ASP B 382 85.23 24.96 REMARK 500 ARG B 465 -0.74 70.57 REMARK 500 ASP B 484 90.26 74.87 REMARK 500 TYR B 515 26.18 49.29 REMARK 500 PRO B 561 151.08 -47.36 REMARK 500 LYS B 573 -49.99 168.61 REMARK 500 ASP B 652 98.13 -68.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 461 ILE A 462 -146.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 19 DISTANCE = 6.21 ANGSTROMS REMARK 525 HOH B 17 DISTANCE = 6.57 ANGSTROMS REMARK 525 HOH A 71 DISTANCE = 5.69 ANGSTROMS REMARK 525 HOH A 73 DISTANCE = 5.24 ANGSTROMS REMARK 525 HOH A 74 DISTANCE = 7.23 ANGSTROMS REMARK 525 HOH A 80 DISTANCE = 6.42 ANGSTROMS REMARK 525 HOH A 93 DISTANCE = 5.41 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PDS A 901 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PDS B 902 REMARK 999 REMARK 999 SEQUENCE REMARK 999 ACCORDING TO THE AUTHORS OF THE ENTRY, CONFLICTS ARISE REMARK 999 BETWEEN THEIR SEQUENCE AND THE UNP REFERENCE SEQUENCE REMARK 999 BECAUSE THEIR SEQUENCE IS OF PKC-BETAII AND THE UNP REMARK 999 REFERENCE SEQUENCE IS OF PKC-BETAI. DBREF 2I0E A 321 670 UNP P05771 KPCB_HUMAN 320 670 DBREF 2I0E B 321 670 UNP P05771 KPCB_HUMAN 320 670 SEQADV 2I0E TPO A 500 UNP P05771 THR 499 MODIFIED RESIDUE SEQADV 2I0E A UNP P05771 ARG 621 SEE REMARK 999 SEQADV 2I0E CYS A 622 UNP P05771 ASP 622 SEE REMARK 999 SEQADV 2I0E GLY A 623 UNP P05771 LYS 623 SEE REMARK 999 SEQADV 2I0E ASN A 625 UNP P05771 ASP 625 SEE REMARK 999 SEQADV 2I0E ALA A 626 UNP P05771 THR 626 SEE REMARK 999 SEQADV 2I0E GLU A 627 UNP P05771 SER 627 SEE REMARK 999 SEQADV 2I0E ARG A 631 UNP P05771 LYS 631 SEE REMARK 999 SEQADV 2I0E PHE A 632 UNP P05771 GLU 632 SEE REMARK 999 SEQADV 2I0E HIS A 636 UNP P05771 GLN 636 SEE REMARK 999 SEQADV 2I0E PRO A 638 UNP P05771 VAL 638 SEE REMARK 999 SEQADV 2I0E VAL A 639 UNP P05771 GLU 639 SEE REMARK 999 SEQADV 2I0E TPO A 641 UNP P05771 THR 641 MODIFIED RESIDUE SEQADV 2I0E PRO A 643 UNP P05771 THR 643 SEE REMARK 999 SEQADV 2I0E GLN A 645 UNP P05771 LYS 645 SEE REMARK 999 SEQADV 2I0E GLU A 646 UNP P05771 LEU 646 SEE REMARK 999 SEQADV 2I0E VAL A 647 UNP P05771 PHE 647 SEE REMARK 999 SEQADV 2I0E ARG A 649 UNP P05771 MET 649 SEE REMARK 999 SEQADV 2I0E ILE A 651 UNP P05771 LEU 651 SEE REMARK 999 SEQADV 2I0E SER A 654 UNP P05771 ASN 654 SEE REMARK 999 SEQADV 2I0E GLU A 657 UNP P05771 ALA 657 SEE REMARK 999 SEQADV 2I0E SEP A 660 UNP P05771 SER 660 MODIFIED RESIDUE SEQADV 2I0E PHE A 661 UNP P05771 TYR 661 SEE REMARK 999 SEQADV 2I0E VAL A 662 UNP P05771 THR 662 SEE REMARK 999 SEQADV 2I0E SER A 664 UNP P05771 PRO 664 SEE REMARK 999 SEQADV 2I0E LEU A 667 UNP P05771 VAL 667 SEE REMARK 999 SEQADV 2I0E LYS A 668 UNP P05771 ILE 668 SEE REMARK 999 SEQADV 2I0E PRO A 669 UNP P05771 ASN 669 SEE REMARK 999 SEQADV 2I0E GLU A 670 UNP P05771 VAL 670 SEE REMARK 999 SEQADV 2I0E VAL A 671 UNP P05771 SEE REMARK 999 SEQADV 2I0E LYS A 672 UNP P05771 SEE REMARK 999 SEQADV 2I0E SER A 673 UNP P05771 SEE REMARK 999 SEQADV 2I0E TPO B 500 UNP P05771 THR 499 MODIFIED RESIDUE SEQADV 2I0E B UNP P05771 ARG 621 SEE REMARK 999 SEQADV 2I0E CYS B 622 UNP P05771 ASP 622 SEE REMARK 999 SEQADV 2I0E GLY B 623 UNP P05771 LYS 623 SEE REMARK 999 SEQADV 2I0E ASN B 625 UNP P05771 ASP 625 SEE REMARK 999 SEQADV 2I0E ALA B 626 UNP P05771 THR 626 SEE REMARK 999 SEQADV 2I0E GLU B 627 UNP P05771 SER 627 SEE REMARK 999 SEQADV 2I0E ARG B 631 UNP P05771 LYS 631 SEE REMARK 999 SEQADV 2I0E PHE B 632 UNP P05771 GLU 632 SEE REMARK 999 SEQADV 2I0E HIS B 636 UNP P05771 GLN 636 SEE REMARK 999 SEQADV 2I0E PRO B 638 UNP P05771 VAL 638 SEE REMARK 999 SEQADV 2I0E VAL B 639 UNP P05771 GLU 639 SEE REMARK 999 SEQADV 2I0E TPO B 641 UNP P05771 THR 641 MODIFIED RESIDUE SEQADV 2I0E PRO B 643 UNP P05771 THR 643 SEE REMARK 999 SEQADV 2I0E GLN B 645 UNP P05771 LYS 645 SEE REMARK 999 SEQADV 2I0E GLU B 646 UNP P05771 LEU 646 SEE REMARK 999 SEQADV 2I0E VAL B 647 UNP P05771 PHE 647 SEE REMARK 999 SEQADV 2I0E ARG B 649 UNP P05771 MET 649 SEE REMARK 999 SEQADV 2I0E ILE B 651 UNP P05771 LEU 651 SEE REMARK 999 SEQADV 2I0E SER B 654 UNP P05771 ASN 654 SEE REMARK 999 SEQADV 2I0E GLU B 657 UNP P05771 ALA 657 SEE REMARK 999 SEQADV 2I0E SEP B 660 UNP P05771 SER 660 MODIFIED RESIDUE SEQADV 2I0E PHE B 661 UNP P05771 TYR 661 SEE REMARK 999 SEQADV 2I0E VAL B 662 UNP P05771 THR 662 SEE REMARK 999 SEQADV 2I0E SER B 664 UNP P05771 PRO 664 SEE REMARK 999 SEQADV 2I0E LEU B 667 UNP P05771 VAL 667 SEE REMARK 999 SEQADV 2I0E LYS B 668 UNP P05771 ILE 668 SEE REMARK 999 SEQADV 2I0E PRO B 669 UNP P05771 ASN 669 SEE REMARK 999 SEQADV 2I0E GLU B 670 UNP P05771 VAL 670 SEE REMARK 999 SEQADV 2I0E VAL B 671 UNP P05771 SEE REMARK 999 SEQADV 2I0E LYS B 672 UNP P05771 SEE REMARK 999 SEQADV 2I0E SER B 673 UNP P05771 SEE REMARK 999 SEQRES 1 A 353 THR THR ASN THR VAL SER LYS PHE ASP ASN ASN GLY ASN SEQRES 2 A 353 ARG ASP ARG MET LYS LEU THR ASP PHE ASN PHE LEU MET SEQRES 3 A 353 VAL LEU GLY LYS GLY SER PHE GLY LYS VAL MET LEU SER SEQRES 4 A 353 GLU ARG LYS GLY THR ASP GLU LEU TYR ALA VAL LYS ILE SEQRES 5 A 353 LEU LYS LYS ASP VAL VAL ILE GLN ASP ASP ASP VAL GLU SEQRES 6 A 353 CYS THR MET VAL GLU LYS ARG VAL LEU ALA LEU PRO GLY SEQRES 7 A 353 LYS PRO PRO PHE LEU THR GLN LEU HIS SER CYS PHE GLN SEQRES 8 A 353 THR MET ASP ARG LEU TYR PHE VAL MET GLU TYR VAL ASN SEQRES 9 A 353 GLY GLY ASP LEU MET TYR HIS ILE GLN GLN VAL GLY ARG SEQRES 10 A 353 PHE LYS GLU PRO HIS ALA VAL PHE TYR ALA ALA GLU ILE SEQRES 11 A 353 ALA ILE GLY LEU PHE PHE LEU GLN SER LYS GLY ILE ILE SEQRES 12 A 353 TYR ARG ASP LEU LYS LEU ASP ASN VAL MET LEU ASP SER SEQRES 13 A 353 GLU GLY HIS ILE LYS ILE ALA ASP PHE GLY MET CYS LYS SEQRES 14 A 353 GLU ASN ILE TRP ASP GLY VAL THR THR LYS TPO PHE CYS SEQRES 15 A 353 GLY THR PRO ASP TYR ILE ALA PRO GLU ILE ILE ALA TYR SEQRES 16 A 353 GLN PRO TYR GLY LYS SER VAL ASP TRP TRP ALA PHE GLY SEQRES 17 A 353 VAL LEU LEU TYR GLU MET LEU ALA GLY GLN ALA PRO PHE SEQRES 18 A 353 GLU GLY GLU ASP GLU ASP GLU LEU PHE GLN SER ILE MET SEQRES 19 A 353 GLU HIS ASN VAL ALA TYR PRO LYS SER MET SER LYS GLU SEQRES 20 A 353 ALA VAL ALA ILE CYS LYS GLY LEU MET THR LYS HIS PRO SEQRES 21 A 353 GLY LYS ARG LEU GLY CYS GLY PRO GLU GLY GLU ARG ASP SEQRES 22 A 353 ILE LYS GLU HIS ALA PHE PHE ARG TYR ILE ASP TRP GLU SEQRES 23 A 353 LYS LEU GLU ARG LYS GLU ILE GLN PRO PRO TYR LYS PRO SEQRES 24 A 353 LYS ALA CYS GLY ARG ASN ALA GLU ASN PHE ASP ARG PHE SEQRES 25 A 353 PHE THR ARG HIS PRO PRO VAL LEU TPO PRO PRO ASP GLN SEQRES 26 A 353 GLU VAL ILE ARG ASN ILE ASP GLN SER GLU PHE GLU GLY SEQRES 27 A 353 PHE SEP PHE VAL ASN SER GLU PHE LEU LYS PRO GLU VAL SEQRES 28 A 353 LYS SER SEQRES 1 B 353 THR THR ASN THR VAL SER LYS PHE ASP ASN ASN GLY ASN SEQRES 2 B 353 ARG ASP ARG MET LYS LEU THR ASP PHE ASN PHE LEU MET SEQRES 3 B 353 VAL LEU GLY LYS GLY SER PHE GLY LYS VAL MET LEU SER SEQRES 4 B 353 GLU ARG LYS GLY THR ASP GLU LEU TYR ALA VAL LYS ILE SEQRES 5 B 353 LEU LYS LYS ASP VAL VAL ILE GLN ASP ASP ASP VAL GLU SEQRES 6 B 353 CYS THR MET VAL GLU LYS ARG VAL LEU ALA LEU PRO GLY SEQRES 7 B 353 LYS PRO PRO PHE LEU THR GLN LEU HIS SER CYS PHE GLN SEQRES 8 B 353 THR MET ASP ARG LEU TYR PHE VAL MET GLU TYR VAL ASN SEQRES 9 B 353 GLY GLY ASP LEU MET TYR HIS ILE GLN GLN VAL GLY ARG SEQRES 10 B 353 PHE LYS GLU PRO HIS ALA VAL PHE TYR ALA ALA GLU ILE SEQRES 11 B 353 ALA ILE GLY LEU PHE PHE LEU GLN SER LYS GLY ILE ILE SEQRES 12 B 353 TYR ARG ASP LEU LYS LEU ASP ASN VAL MET LEU ASP SER SEQRES 13 B 353 GLU GLY HIS ILE LYS ILE ALA ASP PHE GLY MET CYS LYS SEQRES 14 B 353 GLU ASN ILE TRP ASP GLY VAL THR THR LYS TPO PHE CYS SEQRES 15 B 353 GLY THR PRO ASP TYR ILE ALA PRO GLU ILE ILE ALA TYR SEQRES 16 B 353 GLN PRO TYR GLY LYS SER VAL ASP TRP TRP ALA PHE GLY SEQRES 17 B 353 VAL LEU LEU TYR GLU MET LEU ALA GLY GLN ALA PRO PHE SEQRES 18 B 353 GLU GLY GLU ASP GLU ASP GLU LEU PHE GLN SER ILE MET SEQRES 19 B 353 GLU HIS ASN VAL ALA TYR PRO LYS SER MET SER LYS GLU SEQRES 20 B 353 ALA VAL ALA ILE CYS LYS GLY LEU MET THR LYS HIS PRO SEQRES 21 B 353 GLY LYS ARG LEU GLY CYS GLY PRO GLU GLY GLU ARG ASP SEQRES 22 B 353 ILE LYS GLU HIS ALA PHE PHE ARG TYR ILE ASP TRP GLU SEQRES 23 B 353 LYS LEU GLU ARG LYS GLU ILE GLN PRO PRO TYR LYS PRO SEQRES 24 B 353 LYS ALA CYS GLY ARG ASN ALA GLU ASN PHE ASP ARG PHE SEQRES 25 B 353 PHE THR ARG HIS PRO PRO VAL LEU TPO PRO PRO ASP GLN SEQRES 26 B 353 GLU VAL ILE ARG ASN ILE ASP GLN SER GLU PHE GLU GLY SEQRES 27 B 353 PHE SEP PHE VAL ASN SER GLU PHE LEU LYS PRO GLU VAL SEQRES 28 B 353 LYS SER MODRES 2I0E TPO A 500 THR PHOSPHOTHREONINE MODRES 2I0E TPO A 641 THR PHOSPHOTHREONINE MODRES 2I0E SEP A 660 SER PHOSPHOSERINE MODRES 2I0E TPO B 500 THR PHOSPHOTHREONINE MODRES 2I0E SEP B 660 SER PHOSPHOSERINE HET TPO A 500 11 HET TPO A 641 11 HET SEP A 660 10 HET TPO B 500 11 HET SEP B 660 10 HET PDS A 901 33 HET PDS B 902 33 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM PDS 3-{1-[3-(DIMETHYLAMINO)PROPYL]-2-METHYL-1H-INDOL-3- HETNAM 2 PDS YL}-4-(2-METHYL-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 3(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 PDS 2(C27 H28 N4 O2) FORMUL 5 HOH *115(H2 O) HELIX 1 1 LYS A 375 ASP A 381 1 7 HELIX 2 2 ASP A 383 ALA A 395 1 13 HELIX 3 3 ASP A 427 GLY A 436 1 10 HELIX 4 4 LYS A 439 LYS A 460 1 22 HELIX 5 5 LYS A 468 ASP A 470 5 3 HELIX 6 6 THR A 504 ILE A 508 5 5 HELIX 7 7 ALA A 509 ALA A 514 1 6 HELIX 8 8 LYS A 520 GLY A 537 1 18 HELIX 9 9 ASP A 545 HIS A 556 1 12 HELIX 10 10 SER A 565 MET A 576 1 12 HELIX 11 11 GLU A 589 GLU A 596 1 8 HELIX 12 12 HIS A 597 ARG A 601 5 5 HELIX 13 13 ASP A 604 ARG A 610 1 7 HELIX 14 14 GLU A 627 HIS A 636 1 10 HELIX 15 15 ASP A 644 ILE A 651 1 8 HELIX 16 16 LYS B 375 ASP B 382 1 8 HELIX 17 17 ASP B 383 ALA B 395 1 13 HELIX 18 18 ASP B 427 GLN B 434 1 8 HELIX 19 19 LYS B 439 LYS B 460 1 22 HELIX 20 20 LYS B 468 ASP B 470 5 3 HELIX 21 21 ALA B 509 ALA B 514 1 6 HELIX 22 22 LYS B 520 GLY B 537 1 18 HELIX 23 23 ASP B 545 HIS B 556 1 12 HELIX 24 24 SER B 565 LEU B 575 1 11 HELIX 25 25 HIS B 579 ARG B 583 5 5 HELIX 26 26 GLU B 589 GLU B 596 1 8 HELIX 27 27 HIS B 597 ARG B 601 5 5 HELIX 28 28 ASP B 604 ARG B 610 1 7 HELIX 29 29 ASP B 652 GLU B 657 5 6 SHEET 1 A 6 PHE A 342 GLY A 351 0 SHEET 2 A 6 GLY A 354 ARG A 361 -1 O VAL A 356 N LEU A 348 SHEET 3 A 6 THR A 364 LYS A 374 -1 O ILE A 372 N LYS A 355 SHEET 4 A 6 ARG A 415 GLU A 421 -1 O LEU A 416 N LEU A 373 SHEET 5 A 6 LEU A 406 GLN A 411 -1 N HIS A 407 O VAL A 419 SHEET 6 A 6 PHE A 661 VAL A 662 -1 O PHE A 661 N CYS A 409 SHEET 1 B 2 VAL A 472 LEU A 474 0 SHEET 2 B 2 ILE A 480 ILE A 482 -1 O LYS A 481 N MET A 473 SHEET 1 C 6 PHE B 342 GLY B 351 0 SHEET 2 C 6 GLY B 354 ARG B 361 -1 O GLY B 354 N GLY B 351 SHEET 3 C 6 LEU B 367 LYS B 374 -1 O ILE B 372 N LYS B 355 SHEET 4 C 6 ARG B 415 GLU B 421 -1 O LEU B 416 N LEU B 373 SHEET 5 C 6 LEU B 406 THR B 412 -1 N THR B 412 O ARG B 415 SHEET 6 C 6 PHE B 661 VAL B 662 -1 O PHE B 661 N CYS B 409 SHEET 1 D 2 VAL B 472 LEU B 474 0 SHEET 2 D 2 ILE B 480 ILE B 482 -1 O LYS B 481 N MET B 473 LINK C LYS A 499 N TPO A 500 1555 1555 1.33 LINK C TPO A 500 N PHE A 501 1555 1555 1.33 LINK C LEU A 640 N TPO A 641 1555 1555 1.34 LINK C TPO A 641 N PRO A 642 1555 1555 1.35 LINK C PHE A 659 N SEP A 660 1555 1555 1.33 LINK C SEP A 660 N PHE A 661 1555 1555 1.33 LINK C LYS B 499 N TPO B 500 1555 1555 1.33 LINK C TPO B 500 N PHE B 501 1555 1555 1.33 LINK C PHE B 659 N SEP B 660 1555 1555 1.33 LINK C SEP B 660 N PHE B 661 1555 1555 1.33 SITE 1 AC1 14 HOH A 57 LEU A 348 PHE A 353 VAL A 356 SITE 2 AC1 14 ALA A 369 THR A 404 GLU A 421 TYR A 422 SITE 3 AC1 14 VAL A 423 ASP A 470 ASN A 471 MET A 473 SITE 4 AC1 14 ALA A 483 ASP A 484 SITE 1 AC2 13 HOH B 59 LEU B 348 VAL B 356 ALA B 369 SITE 2 AC2 13 THR B 404 MET B 420 GLU B 421 TYR B 422 SITE 3 AC2 13 VAL B 423 ASP B 470 ASN B 471 ALA B 483 SITE 4 AC2 13 ASP B 484 CRYST1 93.098 131.417 83.801 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010741 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007609 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011933 0.00000 MASTER 415 0 7 29 16 0 8 6 0 0 0 56 END